Welcome to the international HTA database

Showing [24038 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2010	NIHR Health Technology Assessment programme	Virus shedding and environmental deposition of novel A(H1N1) pandemic influenza virus
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Methods to screen for hemoglobin S in blood donors selected for exchange transfusions: a review of the clinical effectiveness and guidelines
2010	National Institute for Health and Care Excellence (NICE)	Haemorrhoidal artery ligation. NICE interventional procedures guidance 342
2010	NIHR Health Technology Assessment programme	Evaluation of triage methods used to select patients with suspected pandemic influenza for hospital admission: cohort study
2010	HAYES, Inc.	Paclitaxel-eluting stents for treatment of coronary artery disease
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Optimizing the implementation of diagnostic imaging decision support tools: a review of the evidence and guidelines
2010	National Institute for Health and Care Excellence (NICE)	Arteriovenous crossing sheathotomy for branch retinal vein occlusion. NICE interventional procedures guidance 334
2010	NIHR Health Technology Assessment programme	Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03B/oil-in-water emulsion- adjuvanted (AS03B) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age
2010	HAYES, Inc.	Photodynamic therapy for actinic keratosis and squamous cell carcinoma in situ
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cannabinoids as co-analgesics: review of clinical effectiveness
2010	National Institute for Health and Care Excellence (NICE)	Endoscopic submucosal dissection of lower gastrointestinal lesions. NICE interventional procedures guidance 335
2010	NIHR Health Technology Assessment programme	Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings
2010	HAYES, Inc.	Photodynamic therapy for nonmelanoma skin cancer
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Phosphodiesterase 5 inhibitors: a review of the clinical effectiveness and cost-effectiveness
2010	National Institute for Health and Care Excellence (NICE)	Transcatheter endovascular closure of perimembranous ventricular septal defect. NICE interventional procedures guidance 336
2010	Institute for Clinical Effectiveness and Health Policy (IECS)	[Sperm DNA fragmentation and annexin column use in assisted reproductive treatments]
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Negative pressure therapy for patients infected wounds: a review of the clinical and cost-effectiveness evidence and recommendations for use
2010	National Institute for Health and Care Excellence (NICE)	Endobronchial ultrasound-guided transbronchial biopsy for peripheral lung lesions. NICE interventional procedures guidance 337
2010	Institute for Clinical Effectiveness and Health Policy (IECS)	[Gefitinib for the treatment of lung cancer]
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Silver dressings for the treatment of patients with infected wounds: a review of clinical and cost-effectiveness
2010	National Institute for Health and Care Excellence (NICE)	Surgical correction of hallux valgus using minimal access techniques. NICE interventional procedures guidance 332
2010	Institute for Clinical Effectiveness and Health Policy (IECS)	[Levonorgestrel-releasing intrauterine device (IUD) for patients with hypermenorrhea]
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Patient lifts and transfer equipment: a review of clinical and cost-effectiveness and guidelines
2010	National Institute for Health and Care Excellence (NICE)	Therapeutic endoscopic division of epidural adhesions. NICE interventional procedures guidance 333
2010	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of serum-free light chain measurement in monoclonal gammopathy]
2010	Finnish Office for Health Care Technology Assessment (Finohta)	[18Fluorodeoxyglucose positron emission tomography in the assessment of patients with potentially curable cancer]
2010	HAYES, Inc.	Psychosocial interventions as adjunct treatments for pediatric bipolar disorder
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Chair alarms in residential care and acute care: a review of the clinical effectiveness and safety
2010	Institute for Clinical Effectiveness and Health Policy (IECS)	[Positron emission tomography (PET): diagnostic usefulness and indications]
2010	HAYES, Inc.	Quantitative computed tomography for bone mineral density
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Deep brain stimulation for parkinson's disease and neurological movement disorders: a review of the clinical and cost-effectiveness and guidelines
2010	Institute of Health Economics (IHE)	Routine preoperative electrocardiogram and chest x-ray prior to elective surgery in Alberta, Canada
2010	Institute for Clinical and Economic Review (ICER)	Atrial fibrillation management options
2010	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of detecting rearrangement of FIP1L1-PDGFRA in patients with primary hypereosinophilic syndrome]
2010	Finnish Office for Health Care Technology Assessment (Finohta)	[Mechanical non-invasive cough assist device]
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bupropion for adults with attention deficit hyperactivity disorder: a review of the clinical effectiveness and harms of misuse
2010	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Vision screening of preschool children]
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Cx501 for cutaneous lesions associated with recessive dystrophic epidermolysis bullosa
2010	Health Council of the Netherlands Gezondheidsraad (GR)	The 'thousand-dollar genome': an ethical exploration
2010	HAYES, Inc.	Rotating platform knee arthroplasty
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Treatment of periodontal disease in patients with diabetes: a review of clinical and cost-effectiveness
2010	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Multidisciplinary and multisectoral interventions targeting patients with back pain – a health technology assessment]
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Dabigatran etexilate (Pradaxa) for secondary prevention of venous thromboembolism (VTE)
2010	Finnish Office for Health Care Technology Assessment (Finohta)	[Fluorescence cystoscopy in diagnosis and management of superficial bladder cancer]
2010	Health Services Assessment Collaboration (HSAC)	A systematic review of economic evaluations for tobacco control programs
2010	Health Council of the Netherlands Gezondheidsraad (GR)	[Prenatal screening for trisomy 13 and 18]
2010	HAYES, Inc.	Routine ultrasound examination in low-risk pregnancy
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Drug therapy for prophylactic and post-exposure treatment of H1N1: a review of the comparative clinical and cost-effectiveness
2010	The Swedish Council on Health Technology Assessment (SBU)	[Silver-releasing dressings in treating chronic wounds]
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Dienogest (Visabelle) for recurrent endometriosis - second or third line
2010	Health Services Assessment Collaboration (HSAC)	The effectiveness of non-pharmacological interventions for behavioural and psychological symptom management for people with dementia in residential care settings
2010	HAYES, Inc.	Screening, brief intervention, and referral to treatment (sbirt) for illicit drug use
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Lindane and other treatments for lice and scabies: a review of clinical effectiveness and safety
2010	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Autologous fat transfer for cosmetic and reconstructive breast augmentation
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Duloxetine (Cymbalta) for chronic somatic pain
2010	Basque Office for Health Technology Assessment (OSTEBA)	[Review of the psychological treatment in first psychotic episode]
2010	HAYES, Inc.	Sirolimus-analog-eluting stents for treatment of coronary artery disease
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Positron emission tomography for epilepsy: clinical effectiveness and guidelines
2010	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Hip protectors in long-term care]
2010	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Detection of high risk human papillomavirus E6 and E7 oncogenes for cervical cancer screening]
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Ivabradine (Procoralan) for chronic heart failure
2010	Basque Office for Health Technology Assessment (OSTEBA)	[Map on shared resources in HTA and Health Services]
2010	HAYES, Inc.	Sirolimus-eluting stents for treatment of coronary artery disease
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bluetooth-enabled hearing technologies: a review of the clinical and cost-effectiveness
2010	NIHR Health Technology Assessment programme	Self monitoring of blood glucose in type 2 diabetes
2010	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Applicability of sentinel-lymph-node detection and biopsy in the treatment of vulval cancer]
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Linagliptin (Ondero) for type 2 diabetes mellitus - monotherapy or add-on therapy
2010	Basque Office for Health Technology Assessment (OSTEBA)	[Examination of barriers and facilitators for the implementation of clinical practice guidelines: a Delphi study]
2010	HAYES, Inc.	Total wrist arthroplasty
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Varenicline for smoking cessation in patients with psychiatric illness: a review of the risks
2010	Medical Advisory Secretariat (MAS)	Clinical utility of vitamin D testing: an evidence-based analysis
2010	Medical Advisory Secretariat (MAS)	Clinical utility of serologic testing for celiac disease in Ontario (symptomatic patients)
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Panitumumab (Vectibix) metastatic and/or recurrent head and neck cancer - first line
2010	Basque Office for Health Technology Assessment (OSTEBA)	[Design and implementation plan of telemedicine in specific clinical areas: telemonitoring and teledermatology. Assessment of initial results and costs]
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pain scales in acute care settings: a review of the accuracy and reliability
2010	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Non-medical intervention for people with or without dementia]
2010	NIHR Health Technology Assessment programme	Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the reduction of morphine-related side-effects after major surgery: a systematic review
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Panobinostat (Faridak) for relapsed or refractory classical Hodgkin's lymphoma - third line
2010	Health Services Assessment Collaboration (HSAC)	Hypomethylating agents in the treatment of myelodysplastic syndromes: horizon scanning report
2010	HAYES, Inc.	Ventricular Assist Devices (VADs) in children and adolescents with chronic, end-stage heart failure
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Prefabricated and custom made foot orthotics: a review of the clinical and cost-effectiveness
2010	NIHR Health Technology Assessment programme	Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment
2010	NIHR Health Technology Assessment programme	Development of the protocol for the proposed trial of beta interferon in multiple sclerosis
2010	NIHR Health Technology Assessment programme	Certolizumab pegol (CIMZIA) for the treatment of rheumatoid arthritis
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Infliximab for maintenance therapy for treatment of Crohn's disease: a review of the clinical effectiveness and guidelines
2010	Canary Health Service	[Barriers and facilitators to implementation of shared decision-making]
2010	NIHR Health Technology Assessment programme	Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Autism spectrum disorder: scientific knowledge about the detection, diagnosis and treatment]
2010	Finnish Office for Health Care Technology Assessment (Finohta)	Management of infection in patients in health centres. Final report of the MIKSTRA programme
2010	NIHR Health Technology Assessment programme	Capecitabine for the treatment of advanced gastric cancer
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Percutaneous heart valves for valvular heart disease: an updated review of the clinical and cost-effectiveness and guidelines
2010	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation
2010	NIHR Health Technology Assessment programme	Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Albumin versus synthetic plasma volume expanders: a review of the clinical and cost-effectiveness and guidelines for use
2010	Canary Health Service	[Cost-effectiveness of knowledge transfer methods]
2010	NIHR Health Technology Assessment programme	The safety and effectiveness of different methods of ear wax removal: a systematic review and economic evaluation
2010	Health Services Assessment Collaboration (HSAC)	A comparison of gene expression profiling tests for breast cancer
2010	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcatheter aortic valve implantation: a critical appraisal of a health technology assessment and comparison with a rapid review
2010	Canary Health Service	[Effectiveness of cardiovascular risk communication]